Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (5325)	7/15/1998 12:29:00 PM
From: Biomaven	Respond to of 9719

Check out PCYC's roto-rooter news: Message 5202239 Early days yet, but lots of potential. Peter

To: Thomas M. who wrote (5325)	7/15/1998 6:36:00 PM
From: Peter Singleton	Respond to of 9719

so, Andreas, Tom, Peter ... continuing from my previous post ... just got tired of typing in that editor. So, I'm looking for biotech stock picks, and I'm trying to figure out how to make informed decisions on them ... a model for first assessing value then monitoring change that's specific to that company. There's no place I can go for that, so I have to come up with one on my own. But that takes an incredible amount of time (lots and lots and lots of hours). Here's what I do. I'd be interested in hearing how you do it: - get the most detailed company info I can (ann rep, 10k, analyst reports, press releases, scientific articles). read everything. btw, I hate it when a company won't give out analyst reports and scientific articles. as a matter of policy, I won't invest in the company ... - try and keep up with the industry the company is playing in (competitors, etc.) - find the best online stock thread (usually SI, but occasionally Yahoo now and before Motley Fool), then read the thread ... or a substantial portion of it. That's why I dislike the coffee shop / express yourself threads like LGND ... I have to sift through 30 - 40 posts to get one on post. - attempt to get a sense of the critical issues contributing to risk and value of the company ... both current and future - visit the company. also observe them giving pitches to the investment community. this is absolutely essential, but is of limited value until I've done the upfront work. Here's my problem. Suppose that it takes 20 - 40 hours to do the due diligence on a given company, then an hour or two (at minimum) per week to keep up to date. My numbers maybe off, but you get the picture. How do I sift through the 300 or so publically traded biotechs to create a hit list for detailed evaluation? Then, out of that hit list of maybe 30 companies, where do I find the time to evaluate them to come up with a list of perhaps 10 to invest in. More than 10, it's very difficult to find the time to stay up to speed on. Plus, you're getting close to the point of diversification where a fund of some sort becomes more advisable than picking your own stocks. Too many fewer than 10, and you're raising your risk on your portfolio, substantially (trust me, I know). So, trying to construct a informed, well-chosen portfolio of biotechs appears to be like a bumble bee flying. It's simply not possible. There's not enough time in a week or a month or a year. ... I'll continue for one last post in the next post ... I'm wearing out ... : )